As a journalist, I long have been fascinated by reporting on the storytelling forces within American medicine that create societal understanding of the merits of its treatments. I write about this in my new book, Anatomy of an Epidemic, and investigate whether the story told by American psychiatry about mental disorders and its drugs—i.e. that they are safe and effective agents that fix chemical imbalances in the brain—is consistent with the underlying science. In other words, I investigate whether the American public is being told an honest story, or one that serves the financial interests of psychiatry and the makers of the drugs.

Now my book was released on Tuesday, April 13, and the next day a review appeared in the Boston Globe, written by Dennis Rosen, an instructor in pediatrics at Harvard Medical School. Dr. Rosen also posted a link on his Psychology Today blog to his review, and then I posted a brief response. But as I mulled over the review some more, I realized that it neatly illustrates the story-telling process that I write about in the book. I thought about explaining how that is so on this site, for the subject --storytelling in the modern era of corporate medicine-- is an important one. But  my explanation is a long one, and much as Dr. Rosen pointed to his Boston Globe review of the book through a link, I thought it best to put up that explanation on a website that I have had since I wrote my first book, Mad in America. The post simply looks at whether the review, in its presentation of the book, does so with any accuracy, and the purpose that might be served by the review, in its final paragraph, likening me to an AIDS denier.

Recent Posts in Mad in America

The Real Suicide Data from the TADS Study Comes to Light

NIMH hid suicide risk in pediatric study

Can Unethical Research Ever Lead to "Best Evidence?"

Study Was Expected to Make Psychotic Patients Worse

A Rorschach Test for Psych Meds

Off Meds and Enjoying Robust Recovery: Reimagining What Is Possible

Anatomy of an Epidemic Down Under

Psychiatric disability numbers rise in Australia and New Zealand

In Defense of Psychiatric Medications, Part Two

More on psychiatry's response to Marcia Angell